Novo Nordisk sues Eli Lilly, accusing it of false advertising
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's.
Novo Nordisk says it’s suing Eli Lilly, accusing it of false advertising
Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo’s Wegovy and Ozempic while omitting newer, higher-dose versions that Novo says deliver greater weight ...
Novo Sues Rival Lilly Over Alleged False Advertising in Weight-Loss Ads
The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements.
NBC Los Angeles
Novo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising
Two of the world's biggest pharmaceutical companies are headed to court after Novo Nordisk, the maker of Ozempic and a pioneer in diabetes and obesity treatments, sued rival Eli Lilly on Tuesday, ...
Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and ...